RxDoctor Payments Data

Cheri Seeley

Physician Assistant · Golden, CONPI 1477731362

Payments from drug & device makers

$1,893in general payments, 2019–2025

Across 61 payments — averaging $31.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$302
  • Seagen Inc.$207
  • Pfizer$161
  • Takeda Pharmaceuticals U.S.A., Inc.$145
  • Exelixis Inc.$125
  • Sobi, Inc$99
  • plus $854 from 21 others

What the payments were for

  • Food & beverage$1,08457%
  • Education$80943%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,893 in reported general payments places this provider in the 85th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$20,525
Medicare patients
129
Services billed
296

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JakafiRuxolitinib Phosphate18$303,040
ImbruvicaIbrutinib19$276,900
Lenalidomide13$216,859
NubeqaDarolutamide11$128,400
XareltoRivaroxaban25$22,416
EliquisApixaban13$18,104
Abiraterone Acetate11$1,426
Anastrozole29$629
Letrozole13$368
Hydroxyurea17$326
Acyclovir17$146
Prednisone17$47
Furosemide16$46
Prochlorperazine Maleate14$40

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Incyte CorporationJakafi$31$303,04018 claims
Pharmacyclics LLC, An Abbvie CompanyImbruvica$27$276,90019 claims
BayerNubeqa$53$128,40011 claims
Johnson & JohnsonXarelto$302$22,41625 claims
PfizerEliquis$161$18,10413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Golden

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →